Table 4.

Sensitivities for individual and combined tumor marker assays for all endometrial cancer stages.

Marker Combination	Controls vs. Endometrial Cancer - All Stages Average Sensitivity as Set Specificity of:
	90%	95%	98%
CA125	34.6%	24.6%	15.6%
HE4	55.0%	45.5%	36.7%
CA72.4	10.2%	7.3%	4.4%
SMRP	11.3%	7.1%	3.1%
CA125 + HE4	57.3%	50.1%	39.8%
CA125 + CA72.4	34.5%	24.6%	16.7%
CA125 + SMRP	34.1%	25.1%	15.6%
HE4 + CA72.4	55.0%	45.0%	36.6%
HE4 + SMRP	53.8%	44.8%	36.3%
CA125 + HE4 + CA72.4	57.2%	48.9%	40.6%
CA125 + HE4 + SMRP	56.6%	48.4%	38.2%
CA125 + CA72.4 + SMRP	34.8%	24.7%	16.8%
HE4 + CA72.4 + SMRP	54.3%	44.8%	36.3%
CA125 + HE4 + CA72.4 + SMRP	57.3%	47.5%	40.0%